You are here

Home » Content

Ailevi Hiperkolesterolemi (2 olgu nedeniyle)

Familial hypercholesterolemia : report of two cases

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 1997

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Familial hypercholesterolemia is a genetic disorder due to an autosomal dominant defect in the gene coding the low density lipoprotein receptor and results in increased plasma levels of low density lipoprotein cholesterol. In this article, two patients diagnosed as familial hypercholesterolemia were presented and the pathogenesis, clinical findings, and therapeutic aspects of familial hypercholesterolemia were reviewed. [Journal of Turgut Özal Medical Center 1997;4(3):302-305]
Bookmark/Search this post with
Abstract (Original Language): 
Ailevi hiperkolesterolemi, düşük dansiteli lipoprotein reseptör genindeki otozomal dominat defekt sonucu plazmada düşük dansiteli lipoprotein kolesterolün artışı ile giden, kalıtsal bir hastalıktır. Bu makalede ailevi hiperkolesterolemi tanısı alan iki olgu sunuldu. Ailevi hiperkolesteraleminin etyopatogenezi, klinik özellikleri ve tedavisi gözden geçirildi. [Turgut Özal Tıp Merkezi Dergisi 1997;4(3):302-305]
FULL TEXT (PDF): 
PDF icon arastirmax-ailevi-hiperkolesterolemi-2-olgu-nedeniyle.pdf
  • 3
302-305
  • Turkish

REFERENCES

References: 

1. Goldstein Jl, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Diseases. 7th ed. NY McGraw-Hill Inc 1995:1981-2030.
2. Mellies MJ, Rymaszewski Z, Glveck CJ. Atherosclerosis. In: Adams FH, Emmanoulidies GC, Riemesenschneider TA, eds. Heart Disease in Infants, Children and Adeloscents. Baltimore:
Williams and Wilkins Co 1989:801-2.
3. Sprecher DL, Hoeg JM, Schaefer EJ, Zech LA, Gregg RE, Lakatos E, Brewer HB Jr. The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia. Metabolism 1985;
34: 294-9.
4. Fredrickson DS, Levy RI. Familial hyperlipoproteinemia. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, eds. The Metabolic Basis of Inherited Disease. NY: McGraw-Hill Inc; 1972:545-81.
5. Goldstein JL, Brown MS. The LDL- receptor defect in familial
hypercholesterolemia. Med Clin N Am 1982; 66:335-8.
6. Allen JM, Thompson GR, Myant NB, Steiner R, Oakley CM. Cardiovascular complications of homozygous familial
hypercholesterolemia. Br Heart J 1980; 44: 361-8.
7. Garcia RE, Moodie DS. Lipoprotein profiles in
hypercholesterolemic children. AJDC 1991; 84: 147-50.
8.
infarktüs hikayesi olan ailelerin çocuklarında aterosklerotik kalp hastalığı risk faktörleri. Çocuk Sağlığı ve Hastalıkları
Dergisi 1991; 34:115-9.
9. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and
smoking. JAMA 1990; 264: 3018-24.
10. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults.
Arteriosclerosis 1989; 9(suppl I):I-19- 32.
11. Buja LM, Kovanen PT, Bilheimer DW. Cellular pathology of homozygous familial hypercholesterolemia. Am J Pathol 1979;
97: 327-45.
12.
homozigot hiperkolesterolemi (3 olgu nedeniyle). T Klin
Pediatri 1993; 2:201-4.
13. Gagne C,Moorjani S, Brun D, Toussaint M, Lupien PJ. Heterozygous familial hypercholesterolemia. Relationship between plasma lipids, lipoproteins, clinical manifestations and ischaemic heart disease in men and women. Atherosclerosis 1979; 34: 13-24.
14. Seftel HC, Baker SG, sandler MP, Forman MB, Joffe BI,
Mendelsohn D, Jenkins T, Mieny CJ. A host of hypercholesterolaemic homozygotes in South Africa. Br Med J 1980; 281: 633-6.
15. Thompson GR. The hyperlipidaemias. In: Lloyd JK, Scriver CR, eds.Genetic and Metabolic Disease in Pediatrics. London:
Butterworths, 1985:211-33.
16. Lambert M, Lupien PJ, Gagne C, Levy E, Blaichman S, Langlois S, Hayden M, et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of
lovastatin. Pediatrics 1996; 97: 619-28.
17. Raveh D, Israeli A, Arnon R, Eisenberg S. Effects of lovastatin therapy on LDL receptor activity in circulating monocytes and on structure and composition of plasma lipoproteins.
Atherosclerosis 1990; 82:19-26.
18. Stein EA. Treatment of familial hypercholesterolemia with drugs in children. Arteriosclerosis 1989; 9(suppl I): I-145-I-
151.

Thank you for copying data from http://www.arastirmax.com